NO327749B1 - Oksy-substituerte isoflavan-4-ol og isoflav-3-en-forbindelser samt fremgangsmater for fremstilling av de samme - Google Patents

Oksy-substituerte isoflavan-4-ol og isoflav-3-en-forbindelser samt fremgangsmater for fremstilling av de samme Download PDF

Info

Publication number
NO327749B1
NO327749B1 NO20013945A NO20013945A NO327749B1 NO 327749 B1 NO327749 B1 NO 327749B1 NO 20013945 A NO20013945 A NO 20013945A NO 20013945 A NO20013945 A NO 20013945A NO 327749 B1 NO327749 B1 NO 327749B1
Authority
NO
Norway
Prior art keywords
ene
hydroxy
compound
arh
diacetoxy
Prior art date
Application number
NO20013945A
Other languages
English (en)
Norwegian (no)
Other versions
NO20013945D0 (no
NO20013945L (no
Inventor
Andrew Heaton
Naresh Kumar
Original Assignee
Novogen Res Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novogen Res Pty Ltd filed Critical Novogen Res Pty Ltd
Publication of NO20013945D0 publication Critical patent/NO20013945D0/no
Publication of NO20013945L publication Critical patent/NO20013945L/no
Publication of NO327749B1 publication Critical patent/NO327749B1/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/42Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms in positions 2 and 4
    • C07D311/56Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms in positions 2 and 4 without hydrogen atoms in position 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/26Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
    • C07D311/34Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 3 only
    • C07D311/36Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 3 only not hydrogenated in the hetero ring, e.g. isoflavones
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/26Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
    • C07D311/34Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 3 only
    • C07D311/382,3-Dihydro derivatives, e.g. isoflavanones

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
NO20013945A 1999-02-15 2001-08-14 Oksy-substituerte isoflavan-4-ol og isoflav-3-en-forbindelser samt fremgangsmater for fremstilling av de samme NO327749B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPP8685A AUPP868599A0 (en) 1999-02-15 1999-02-15 Production of isoflavone derivatives
PCT/AU2000/000103 WO2000049009A1 (fr) 1999-02-15 2000-02-15 Derives d'isoflavone

Publications (3)

Publication Number Publication Date
NO20013945D0 NO20013945D0 (no) 2001-08-14
NO20013945L NO20013945L (no) 2001-08-14
NO327749B1 true NO327749B1 (no) 2009-09-14

Family

ID=3812886

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20013945A NO327749B1 (no) 1999-02-15 2001-08-14 Oksy-substituerte isoflavan-4-ol og isoflav-3-en-forbindelser samt fremgangsmater for fremstilling av de samme

Country Status (16)

Country Link
US (2) US20050143588A1 (fr)
EP (1) EP1153020A4 (fr)
JP (1) JP2002537295A (fr)
CN (1) CN100564370C (fr)
AU (2) AUPP868599A0 (fr)
BR (1) BR0008222A (fr)
CA (1) CA2362819C (fr)
CZ (1) CZ20012920A3 (fr)
HK (1) HK1041883B (fr)
HU (1) HUP0105218A3 (fr)
IL (2) IL144008A0 (fr)
NO (1) NO327749B1 (fr)
NZ (1) NZ538323A (fr)
TR (1) TR200102367T2 (fr)
WO (1) WO2000049009A1 (fr)
ZA (1) ZA200106502B (fr)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU683838B2 (en) * 1992-05-19 1997-11-27 Novogen Research Pty Ltd Health supplements containing phyto-oestrogens, analogues or metabolites thereof
NZ527735A (en) * 1997-05-01 2005-10-28 Novogen Inc Treatment or prevention of menopausal symptoms and osteoporosis
AUPP260798A0 (en) * 1998-03-26 1998-04-23 Novogen Research Pty Ltd Treatment of medical related conditions with isoflavone containing extracts of clover
US20040072765A1 (en) * 1999-04-28 2004-04-15 Novogen Research Pty Ltd. Cardiovascular and bone treatment using isoflavones
AUPQ266199A0 (en) * 1999-09-06 1999-09-30 Novogen Research Pty Ltd Compositions and therapeutic methods involving isoflavones and analogues thereof
AUPQ520300A0 (en) * 2000-01-21 2000-02-17 Novogen Research Pty Ltd Food product and process
KR100436220B1 (ko) * 2001-08-30 2004-06-12 주식회사 네패스 바닥 반사방지막용 유기 중합체, 그의 제조방법 및 그를함유하는 조성물
JP2005528391A (ja) * 2002-04-09 2005-09-22 ノボゲン リサーチ ピーティーワイ リミテッド イソフラブ−3−エン及びイソフラバン構造を含む治療方法及び組成物
JP2006504409A (ja) * 2002-07-24 2006-02-09 チルドレンズ ホスピタル メディカル センター 鏡像異性のエクオールを含有する組成物および製品、およびその製造方法
US8668914B2 (en) 2002-07-24 2014-03-11 Brigham Young University Use of equol for treating skin diseases
WO2004039327A2 (fr) 2002-10-29 2004-05-13 Colorado State University Research Foundation Utilisation d'equol dans le traitement de maladies d'origine androgenique
AU2003255232A1 (en) 2002-08-07 2004-02-25 University Of Mississippi Antigiardial agents and use thereof
AU2002951271A0 (en) * 2002-09-06 2002-09-19 Novogen Research Pty Ltd Repair of dna mutagenic damage
AU2003257264B2 (en) * 2002-09-06 2007-09-13 Novogen Research Pty Ltd Repair of DNA mutagenic damage
CA2499602A1 (fr) * 2002-09-23 2004-04-01 Graham Edmund Kelly Traitement du photovieillissement et de la deterioration actinique de la peau
AU2002951833A0 (en) 2002-10-02 2002-10-24 Novogen Research Pty Ltd Compositions and therapeutic methods invloving platinum complexes
US8580846B2 (en) 2002-10-29 2013-11-12 Brigham Young University Use of equol for ameliorating or preventing neuropsychiatric and neurodegenerative diseases or disorders
CA2581316C (fr) 2004-09-21 2013-09-10 Novogen Research Pty Ltd Derives de chromane substitues, medicaments et utilisation a des fins therapeutiques
EP1809618B1 (fr) 2004-09-21 2013-07-17 Marshall Edwards, Inc. Dérivés de chromane, médicaments et utilisation à des fins thérapeutiques
US8080675B2 (en) 2004-09-21 2011-12-20 Marshall Edwards, Inc. Chroman derivatives, medicaments and use in therapy
US7528267B2 (en) 2005-08-01 2009-05-05 Girindus America, Inc. Method for enantioselective hydrogenation of chromenes
US7696363B2 (en) * 2005-12-02 2010-04-13 Yasoo Health Inc. Preparation of flavonoid compounds
US20070203227A1 (en) * 2006-02-24 2007-08-30 Herman Adlercreutz Isoflavan and isoflavene compounds and their use as angiogenesis inhibitors
EP2133080A1 (fr) 2008-06-13 2009-12-16 Haelan Schweiz GmbH Compositions contenant de l'équol
US7875736B2 (en) 2009-05-19 2011-01-25 Kaohsiung Medical University Intermediate compounds and processes for the preparation of 7-benzyloxy-3-(4-methoxyphenyl)-2H-1-benzopyran
US7875735B2 (en) 2009-05-19 2011-01-25 Kaohsiung Medical University Processes for preparing isoflavonoids using 7-benzyloxy-3-(4-methoxyphenyl)-2H-1-benzopyran as a starting material
EP2635121B1 (fr) 2010-11-01 2020-01-08 MEI Pharma, Inc. Composés d'isoflavonoïdes et procédés pour le traitement du cancer
US9279082B2 (en) * 2011-01-20 2016-03-08 Merck Patent Gmbh Polymerisable compounds and the use thereof in liquid-crystal displays
WO2014145386A2 (fr) * 2013-03-15 2014-09-18 University Of Florida Research Foundation Incorporated Nouveaux inhibiteurs allostériques de thymidylate synthase
JP2016522167A (ja) * 2013-04-04 2016-07-28 ジ アドミニストレーターズ オブ ザ トゥレーン エデュケーショナル ファンド ヒト間葉系幹細胞に対するダイゼイン類似体の骨形成活性の向上
CN103224481A (zh) * 2013-05-20 2013-07-31 黑龙江大学 一种去氢雌马酚的制备方法
CN107427003B (zh) 2015-02-02 2023-01-31 梅制药公司 联合治疗
WO2016209688A1 (fr) 2015-06-24 2016-12-29 University Of Florida Research Foundation, Incorporated Compositions destinées au traitement du cancer, et leurs utilisations
CN107459554B (zh) * 2016-06-03 2021-03-30 首都医科大学 4’,7-二氧乙酰-apak-5-羟基异黄酮,其合成,活性和应用
CN111303106B (zh) * 2020-03-23 2023-06-02 武汉轻工大学 一种5,6-二乙酰氧基-7-羟基黄酮的制备方法

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1518002C3 (de) * 1965-01-02 1975-01-23 Merck Patent Gmbh, 6100 Darmstadt Isoflavane und Isoflavene und Verfahren zu Ihrer Herstellung sowie diese enthaltende Arzneimittel
DE1543749A1 (de) * 1966-02-16 1969-12-11 Merck Ag E Verfahren zur Herstellung von 3,4-cis-4-Aryl-isoflavanen
JPS5035393A (fr) * 1973-08-01 1975-04-04
JPS576427B2 (fr) * 1974-01-25 1982-02-04
JPS50160483A (fr) * 1974-06-19 1975-12-25
US4264509A (en) * 1977-06-08 1981-04-28 Z-L Limited Partnership Isoflavones and related compounds, methods of preparing and using and antioxidant compositions containing same
US4366082A (en) * 1979-04-11 1982-12-28 Z-L Limited Partnership Isoflavones and related compounds, methods of preparing and using and antioxidant compositions containing same
GB8626344D0 (en) * 1986-11-04 1986-12-03 Zyma Sa Bicyclic compounds
JPH0832632B2 (ja) * 1988-03-08 1996-03-29 株式会社太田胃散 尿素窒素代謝改善剤
JPH02124883A (ja) * 1988-11-04 1990-05-14 Kitasato Inst:The 抗酸化作用を有するイソフラボン誘導体およびその製造法
JPH0686682A (ja) * 1992-07-23 1994-03-29 Kobe Steel Ltd 4’,7,8−トリヒドロキシイソフラボンの製造方法
JPH0640909A (ja) * 1992-07-23 1994-02-15 Kobe Steel Ltd スーパーオキシド・ディスムターゼ様活性剤
JPH0640876A (ja) * 1992-07-23 1994-02-15 Kobe Steel Ltd 紫外線障害防御外用剤
JPH06321752A (ja) * 1993-05-07 1994-11-22 Kao Corp 美白剤
HUT68558A (en) * 1993-07-20 1995-06-28 Chinoin Gyogyszer Es Vegyeszet Method for preparing isoflavon derivatives
AU5970496A (en) * 1995-06-07 1996-12-30 Patrick C. Kung Compounds and methods for promoting hair growth
JPH1059956A (ja) * 1996-08-22 1998-03-03 Kikkoman Corp 新規イソフラボン誘導体及びその製造法
AUPO203996A0 (en) * 1996-08-30 1996-09-26 Novogen Research Pty Ltd Therapeutic uses
AUPP112497A0 (en) * 1997-12-24 1998-01-22 Novogen Research Pty Ltd Compositions and method for protecting skin from UV induced immunosupression and skin damage
AU2183899A (en) * 1998-01-27 1999-08-09 Shionogi & Co., Ltd. Isoflavane derivatives and immunopotentiating compositions containing the same

Also Published As

Publication number Publication date
NZ538323A (en) 2005-10-28
AU2651000A (en) 2000-09-04
IL144008A (en) 2011-03-31
HK1041883A1 (en) 2002-07-26
CZ20012920A3 (cs) 2001-11-14
US20050143588A1 (en) 2005-06-30
CA2362819A1 (fr) 2000-08-24
TR200102367T2 (tr) 2001-11-21
AUPP868599A0 (en) 1999-03-11
CN100564370C (zh) 2009-12-02
HUP0105218A1 (hu) 2002-07-29
US20060217564A1 (en) 2006-09-28
IL144008A0 (en) 2002-04-21
EP1153020A1 (fr) 2001-11-14
HUP0105218A3 (en) 2002-10-28
US7906660B2 (en) 2011-03-15
HK1041883B (zh) 2010-04-23
CN1340048A (zh) 2002-03-13
ZA200106502B (en) 2005-05-09
NO20013945D0 (no) 2001-08-14
EP1153020A4 (fr) 2002-08-21
WO2000049009A1 (fr) 2000-08-24
NO20013945L (no) 2001-08-14
BR0008222A (pt) 2001-10-30
JP2002537295A (ja) 2002-11-05
CA2362819C (fr) 2011-05-10

Similar Documents

Publication Publication Date Title
NO327749B1 (no) Oksy-substituerte isoflavan-4-ol og isoflav-3-en-forbindelser samt fremgangsmater for fremstilling av de samme
CA2617665C (fr) Procede d'hydrogenation enantioselective de chromenes
AU2007304419B2 (en) Process for preparing Nebivolol
AU2009295730B2 (en) Method for preparing nebivolol
KR101829102B1 (ko) 크로마논 2-카르복실산 유도체, 크로만 2-카르복실산 유도체 및 이의 제조방법
WO2005037815A1 (fr) Procede de production de derives d'isoflavane ou d'isoflavene
EP4081206A1 (fr) Préparation de cannabichromène et de cannabinoïdes apparentés
FR3002543A1 (fr) Procede de synthese enzymatique de flavonoides, et application a la synthese de derives de diosmetine
JP4303792B2 (ja) キノロン誘導体の製造方法
WO2005103025A1 (fr) Procede de synthese d'isoflavene et catalyseur
AU2004200117B2 (en) Production of isoflavone derivatives
MXPA01008233A (es) Produccion de derivados de isoflavona
JP2005534682A (ja) イソフラボン類の製造
CN111560000B (zh) 一种多羟基异黄酮的合成方法
AU2007203503A1 (en) Production of isoflavone derivatives
RU2314302C2 (ru) Способ получения производного аминобензопирана
EP4393913A1 (fr) Procédé de préparation de delta-tocotriénol
CA2484585A1 (fr) Procede de preparation de chlorhydrate de benazeprile
WO2024144812A1 (fr) Procédé de préparation de delta-tocotriénol
WO2024145566A1 (fr) PROCÉDÉ DE PRÉPARATION DE δ-TOCOTRIÉNOL
JPH07109268A (ja) 5−アミノフラボン誘導体
JPH11180972A (ja) ジヒドロナフトピラン誘導体

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees